| MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib S Bai, MW Nasser, B Wang, SH Hsu, J Datta, H Kutay, A Yadav, G Nuovo, ... Journal of Biological Chemistry 284 (46), 32015-32027, 2009 | 635 | 2009 |
| Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer Z Qamri, A Preet, MW Nasser, CE Bass, G Leone, SH Barsky, RK Ganju Molecular cancer therapeutics 8 (11), 3117-3129, 2009 | 271 | 2009 |
| Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: Novel anti-tumor mechanisms of Cannabidiol in breast cancer M Elbaz, MW Nasser, J Ravi, NA Wani, DK Ahirwar, H Zhao, S Oghumu, ... Molecular oncology 9 (4), 906-919, 2015 | 227 | 2015 |
| Differential activation and regulation of CXCR1 and CXCR2 by CXCL8 monomer and dimer MW Nasser, SK Raghuwanshi, DJ Grant, VR Jala, K Rajarathnam, ... The Journal of Immunology 183 (5), 3425-3432, 2009 | 217 | 2009 |
| Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non–small cell lung cancer growth and metastasis A Preet, Z Qamri, MW Nasser, A Prasad, K Shilo, X Zou, JE Groopman, ... Cancer prevention research 4 (1), 65-75, 2011 | 173 | 2011 |
| RAGE mediates S100A7-induced breast cancer growth and metastasis by modulating the tumor microenvironment MW Nasser, NA Wani, DK Ahirwar, CA Powell, J Ravi, M Elbaz, H Zhao, ... Cancer research 75 (6), 974-985, 2015 | 143 | 2015 |
| S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways MW Nasser, Z Qamri, YS Deol, J Ravi, CA Powell, P Trikha, ... Cancer research 72 (3), 604-615, 2012 | 143 | 2012 |
| Crosstalk between Chemokine Receptor CXCR4 and Cannabinoid Receptor CB2 in Modulating Breast Cancer Growth and Invasion MW Nasser, Z Qamri, YS Deol, D Smith, K Shilo, X Zou, RK Ganju PloS one 6 (9), e23901, 2011 | 118 | 2011 |
| Fibroblast-derived CXCL12 promotes breast cancer metastasis by facilitating tumor cell intravasation DK Ahirwar, MW Nasser, MM Ouseph, M Elbaz, MC Cuitiño, RD Kladney, ... Oncogene 37 (32), 4428-4442, 2018 | 115 | 2018 |
| CXC motif chemokine 12/CXC chemokine receptor type 7 signaling regulates breast cancer growth and metastasis by modulating the tumor microenvironment NA Wani, MW Nasser, DK Ahirwar, H Zhao, Z Miao, K Shilo, RK Ganju Breast Cancer Research 16, 1-17, 2014 | 115 | 2014 |
| Emerging trends in the immunotherapy of pancreatic cancer K Banerjee, S Kumar, KA Ross, S Gautam, B Poelaert, MW Nasser, ... Cancer letters 417, 35-46, 2018 | 101 | 2018 |
| Depletion of β-arrestin-2 promotes tumor growth and angiogenesis in a murine model of lung cancer SK Raghuwanshi, MW Nasser, X Chen, RM Strieter, RM Richardson The Journal of Immunology 180 (8), 5699-5706, 2008 | 97 | 2008 |
| Focal adhesion kinase a potential therapeutic target for pancreatic cancer and malignant pleural mesothelioma R Kanteti, T Mirzapoiazova, JJ Riehm, I Dhanasingh, B Mambetsariev, ... Cancer biology & therapy 19 (4), 316-327, 2018 | 94 | 2018 |
| TRPV2 is a novel biomarker and therapeutic target in triple negative breast cancer M Elbaz, D Ahirwar, Z Xiaoli, X Zhou, M Lustberg, MW Nasser, K Shilo, ... Oncotarget 9 (71), 33459, 2018 | 85 | 2018 |
| CXCR 3 deficiency enhances tumor progression by promoting macrophage M2 polarization in a murine breast cancer model S Oghumu, S Varikuti, C Terrazas, D Kotov, MW Nasser, CA Powell, ... Immunology 143 (1), 109-119, 2014 | 84 | 2014 |
| MUC4 mucin-a therapeutic target for pancreatic ductal adenocarcinoma SK Gautam, S Kumar, A Cannon, B Hall, R Bhatia, MW Nasser, ... Expert opinion on therapeutic targets 21 (7), 657-669, 2017 | 82 | 2017 |
| The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities U Mehraj, RA Ganai, MA Macha, A Hamid, MA Zargar, AA Bhat, ... Cellular Oncology, 1-21, 2021 | 81 | 2021 |
| FAAH inhibition enhances anandamide mediated anti-tumorigenic effects in non-small cell lung cancer by downregulating the EGF/EGFR pathway J Ravi, A Sneh, K Shilo, MW Nasser, RK Ganju Oncotarget 5 (9), 2475, 2014 | 77 | 2014 |
| Cannabinoid receptor‐2 agonist inhibits macrophage induced EMT in non‐small cell lung cancer by downregulation of EGFR pathway J Ravi, M Elbaz, NA Wani, MW Nasser, RK Ganju Molecular carcinogenesis 55 (12), 2063-2076, 2016 | 76 | 2016 |
| Activation and regulation of platelet-activating factor receptor: role of Gi and Gq in receptor-mediated chemotactic, cytotoxic, and cross-regulatory signals SL Brown, VR Jala, SK Raghuwanshi, MW Nasser, B Haribabu, ... The Journal of Immunology 177 (5), 3242-3249, 2006 | 75 | 2006 |
